Viveve Medical (VIVE) Competitors $0.0001 0.00 (0.00%) As of 07/2/2025 02:56 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock VIVE vs. NMRD, MOTS, UTRS, DRTSW, ANZUW, ATAKW, BBLGW, BRSHW, CTCXW, and CRGTShould you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include Nemaura Medical (NMRD), Motus GI (MOTS), Minerva Surgical (UTRS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), Carmell (CTCXW), and Cortigent (CRGT). These companies are all part of the "medical equipment" industry. Viveve Medical vs. Its Competitors Nemaura Medical Motus GI Minerva Surgical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Bruush Oral Care Carmell Cortigent Viveve Medical (NASDAQ:VIVE) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation. Which has more volatility & risk, VIVE or NMRD? Viveve Medical has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Do institutionals & insiders hold more shares of VIVE or NMRD? 4.4% of Nemaura Medical shares are held by institutional investors. 5.7% of Viveve Medical shares are held by insiders. Comparatively, 40.4% of Nemaura Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media prefer VIVE or NMRD? In the previous week, Viveve Medical's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score. Company Overall Sentiment Viveve Medical Neutral Nemaura Medical Neutral Is VIVE or NMRD more profitable? Company Net Margins Return on Equity Return on Assets Viveve MedicalN/A N/A N/A Nemaura Medical N/A N/A N/A Which has stronger valuation and earnings, VIVE or NMRD? Viveve Medical has higher revenue and earnings than Nemaura Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViveve Medical$6.83M0.00N/AN/AN/ANemaura Medical$3.02K1.34-$14.14M-$0.390.00 SummaryNemaura Medical beats Viveve Medical on 4 of the 5 factors compared between the two stocks. Get Viveve Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VIVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIVE vs. The Competition Export to ExcelMetricViveve MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$28.95M$5.49B$9.01BDividend YieldN/AN/A5.39%4.09%P/E RatioN/A3.1227.4320.06Price / Sales0.00166.79398.25108.31Price / CashN/A41.3636.1356.90Price / BookN/A2.228.085.67Net IncomeN/A-$25.54M$3.16B$248.47M7 Day PerformanceN/A10.77%2.12%2.90%1 Month PerformanceN/A105.70%4.43%5.75%1 Year PerformanceN/A116.48%35.62%21.36% Viveve Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIVEViveve MedicalN/A$0.00flatN/AN/A$1K$6.83M0.0070High Trading VolumeNMRDNemaura Medical0.9822 of 5 stars$0.00flatN/A-99.7%$4K$3.02K0.0040MOTSMotus GI0.0786 of 5 stars$0.00flatN/A-99.3%$2K$319K0.0030News CoverageUTRSMinerva SurgicalN/A$0.00flatN/AN/A$1K$51.69M0.00160DRTSWAlpha Tau MedicalN/A$0.24-3.7%N/A+3.9%$0.00N/A0.0080News CoverageGap DownANZUWAnzu Special Acquisition Corp IN/A$0.04+16.4%N/A-42.6%$0.00N/A0.002ATAKWAurora Technology AcquisitionN/A$0.01-16.7%N/A-61.2%$0.00N/A0.00N/ABBLGWBone BiologicsN/A$15.00flatN/AN/A$0.00N/A0.002Gap UpBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011CTCXWCarmellN/A$0.03+6.8%N/AN/A$0.00$32.84K0.0014Gap UpCRGTCortigentN/AN/AN/AN/A$0.00N/A0.006High Trading Volume Related Companies and Tools Related Companies Nemaura Medical Competitors Motus GI Competitors Minerva Surgical Competitors Alpha Tau Medical Competitors Anzu Special Acquisition Corp I Competitors Aurora Technology Acquisition Competitors Bone Biologics Competitors Bruush Oral Care Competitors Carmell Competitors Cortigent Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIVE) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveve Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveve Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
